Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic
Public ClinicalTrials.gov record NCT04565509. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary goal of this project is to identify the best messaging and implementation strategies to maximize SARS-CoV-2 testing for children with intellectual and developmental disabilities (IDD) and their teachers to help ensure a safe school environment. Additionally, we will understand nationally the perceptions of COVID-19 and identify facilitators and barriers to help with the adoption of testing in other parts of the US and the necessary strategies to address other mitigation strategies including vaccination.
Study identification
- NCT ID
- NCT04565509
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 1,143 participants
Conditions and interventions
Interventions
- Standard Messaging Behavioral
- Enhanced Messaging Behavioral
- COVID-19 Testing Diagnostic Test
- Focus Groups Behavioral
- Fuzzy Cognitive Mapping Behavioral
Behavioral · Diagnostic Test
Eligibility (public fields only)
- Age range
- 5 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 20, 2020 (Actual)
- Primary completion
- Mar 29, 2024 (Actual)
- Completion
- Mar 29, 2024 (Actual)
- Last update posted
- Feb 23, 2026
2020 – 2024
United States locations
- U.S. sites
- 3
- U.S. states
- 2
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Baltimore | Maryland | 21205 | — |
| University of Missouri | Kansas City | Missouri | 64110 | — |
| Special School District | St Louis | Missouri | 63131 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04565509, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 23, 2026 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04565509 live on ClinicalTrials.gov.